Identification of a cDNA Encoding a Retinoid X Receptor Homologue from Schistosoma mansoni
EVIDENCE FOR A ROLE IN FEMALE-SPECIFIC GENE EXPRESSION*

Wendy J. FreebernDagger , Ahmed OsmanDagger , Edward G. Niles§, Linda Christen§, and Philip T. LoVerdeDagger

From the Departments of Dagger  Microbiology and § Biochemistry, and Center for Microbial Pathogenesis, School of Medicine and Biomedical Sciences, State University of New York, Buffalo, New York 14214

    ABSTRACT
Top
Abstract
Introduction
References

Schistosoma mansoni, a multicelluar eukaryotic blood fluke, is a major cause of morbidity worldwide in humans. The study of female parasite growth, development, and gene regulation is important because the eggs produced are responsible for the pathogenesis observed in schistosomiasis. p14, an eggshell precursor gene expressed only in sexually mature females in response to a male stimulus, is a model for female-specific gene regulation. The upstream region of the p14 gene shares sequences present in insect genes known to be regulated in a sex-, temporal-, and tissue-specific manner by members of the steroid receptor superfamily. Herein, we report the identification and characterization of a cDNA that encodes the S. mansoni (Sm) RXR homologue. Sequence analysis predicts and Western blot analysis confirms the synthesis of a 74-kDa protein, the largest member of the RXR family reported to date. We show by electrophoretic mobility shift assay analysis that SmRXR binds to cis-elements of the p14 gene including a direct repeat that follows the "3-4-5" rule of binding elements recognized by members of the steroid receptor superfamily. Furthermore, we demonstrate that SmRXR can act as a transcription activator in the yeast one-hybrid system. Through quantitative reverse transcriptase-polymerase chain reaction, we show that the SmRXR gene is constitutively expressed and thus must play multiple roles throughout the schistosome life cycle.

    INTRODUCTION
Top
Abstract
Introduction
References

Schistosomiasis is a major public health problem afflicting 300 million people in 76 countries (1). Egg production is not only responsible for dissemination of the parasite but also for pathology of the disease in humans. Therefore, studies of female schistosome reproductive development and egg production may define targets useful in disease control. Interestingly, female reproductive development is regulated intimately by a stimulus from the male parasite (2). For many years it has been known that female schistosomes from single sex infections are stunted in size and sexually immature (2). This observation indicates that schistosomes have an intriguing developmental system requiring signaling from the male schistosome leading to direct or indirect activation of a number of female-specific genes (2-6). One gene, p14, encodes an eggshell precursor expressed only in vitelline cells of mature females in response to male stimulus (3, 7, 8). The region upstream of transcription initiation of p14 contains elements similar to those found in Drosophila and silkmoths that are known to regulate chorion gene expression in a sex-, tissue-, and temporal-specific manner (2, 7, 9, 10).

Ultraspiracle protein, a member of the RXR1 subfamily of the steroid receptor superfamily, binds to the s15 chorion gene of Drosophila recognizing an imperfect palindrome containing the core sequence TCACGT (11, 12). Members of the steroid receptor superfamily are likely to play a role in female-specific gene regulation of schistosomes. A similar sequence is present as part of an imperfect palindrome in the upstream region of p14 (2) (Fig. 1). Furthermore, a direct repeat that follows the "3-4-5" rule of steroid response elements is present in the p14 upstream region (13, 14). This latter sequence consists of two identical half-sites, AACTATCA, spaced by five nucleotides (Fig. 1). Presence of these cis-elements in the p14 gene led to a search for schistosome homologues of steroid hormone receptors. Herein, we report the identification and characterization of Schistosoma mansoni RXR cDNA (SmRXR), and we provide evidence for a possible role in regulation of female-specific gene expression.


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 1.   p14 upstream region. The nucleotides in gray are similar to sequences found in insect genes known to be important in regulation of sex-, tissue-, and temporal-specific chorion gene expression. Underlined in gray are cis-elements important for SmRXR interaction as shown by the one-hybrid assay and gel shift assays. The double underlined sequences represent half-sites of a direct repeat or imperfect palindrome, respectively. The sequence of the probe used in EMSA analysis extended from nucleotides -300 to -50. The 154-base pair fragment inserted into the target reporter plasmid mapped from nucleotides -220 to -60. Underlined in dots are consensus CAAAT and TATA boxes, respectively. Nucleotide 1 designates the initiation site for transcription. The start ATG codon is designated by MET (10).


    EXPERIMENTAL PROCEDURES

Identification of SmRXR cDNA-- Degenerate oligonucleotides representing the conserved regions of RXR genes with the amino acid sequences, CEGCKGFF (aa 288-295) and GMKKEAVQEE (aa 335-344), were synthesized for use in PCR (Fig. 2). Using a cDNA pool derived from schistosome worm pair mRNA as a template and the RXR gene-specific primers, a 170-base pair fragment was amplified. This PCR product was cloned into TOPO TA vector (Invitrogen), sequenced, and shown to be related to RXRs by NCBI Blast search analysis. The DNA fragment homologous to RXRs was radiolabeled with [alpha -32P]dCTP by random priming and used as a probe to screen a female adult worm lambda ZAP cDNA library. Seven positive clones were identified, the phagemids were excised, and then the cDNA inserts were shown to be identical in sequence. Amino acid comparison of SmRXR to Drosophila USP and human RXRalpha was performed using the Pile-Up program from the Wisconsin Package version 9. Phylogeny trees were constructed using the PAUPsearch and PAUPdisplay program from the Wisconsin Package version 9. The following parameters were used in construction of trees to confirm accuracy of the study: heuristic with parsimony, branch-and-bound with parsimony, branch-and-bound with minimal evolution, and neighbor joining.


View larger version (64K):
[in this window]
[in a new window]
 
Fig. 2.   Schematic of the functional domains of RXR subfamily members (top). Comparison of the amino acid sequences of SmRXR, dUSP, and human RXRalpha (bottom). Amino acids of SmRXR (accession number AF094759) and dUSP (accession number P20153) that share identity to RXRalpha (accession number P19793) in the highly conserved functional domains are shown in gray. The solid box denotes the amino acids of the DNA binding domain. Asterisks indicate the two zinc fingers of the DNA binding domain. The conserved amino acids of the hinge region are shown in dark gray. The amino acids selected for the synthesis of the oligonucleotides used in PCR to clone the 170-bp SmRXR fragment are underlined. The amino acids of the dimerization and ligand binding domain are boxed in dashed lines. SmRXR sub-domains, tau i and tau c, are located at the amino and carboxyl terminus of the dimerization and ligand binding domain, amino acids 457-512 and 656-676, respectively. Solid boxes within the dimerization and ligand binding domain denote the heptad repeats. The difference in size of SmRXR from other RXR family members occurs at both the amino- and carboxyl-terminal ends of SmRXR by approximately 130-170 amino acids and 50 amino acids, respectively.

Expression and Production of Recombinant SmRXR-- A fragment of SmRXR encoding amino acids 200-561 was inserted into pGEX 2T-1 to form pGEX-RXR. TOP 10 competent cells (Invitrogen) were transformed with pGEX-RXR. Transformed cells were grown to 0.45 A600 at 37 °C and then cooled on ice for 20 min. After the addition of 0.5 mM isopropyl-1-thio-beta -D-galactopyranoside, cells were incubated overnight at 20 °C. The cells were pelleted by centrifugation at 3000 × g for 20 min. Cells were resuspended in lysis buffer (25 mM Tris, pH 8, 1 mM EDTA, 10% glycerol, 50 mM NaCl, 0.1% sodium deoxycholate, 0.01% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride, 10 µM leupeptin and 75 µM aprotinin), sonicated, and the supernatant fraction collected after centrifugation at 18,000 × g for 1 h at 4 °C. The GST-SmRXR fusion protein in the S18 fraction was purified by passage over a glutathione- Sepharose column pre-equilibrated with G-S binding buffer (25 mM Tris, pH 8, 1 mM EDTA, 50 mM NaCl, 10% glycerol). GST-SmRXR was eluted by addition of 10 mM reduced glutathione in G-S binding buffer.

Immunological Techniques-- Rabbit anti-RXR was purified from serum of a rabbit immunized with recombinant GST-SmRXR by the method of Beal and Mitchell (15). Extracts from adult worm pairs, mature male worms, mature female worms, and 3-h schistosomules were loaded onto a 12.5% SDS-acrylamide gel in triplicate panels. One panel was stained with Coomassie Blue, and the other two panels were transferred onto polyvinylidene difluoride membrane (Bio-Rad) for Western analysis. One panel was probed with preimmunized rabbit serum (1:5000 dilution) and the other panel with affinity purified rabbit anti-RXR antibody (2 µg/ml).

Quantification of SmRXR mRNA by RT-PCR-- RNA was extracted from the following schistosome developmental stages: 45-day worms, 44-day female (bisex infection), 44-day male (bisex infection), 44-day female (single sex infection), 44-day male (single sex infection), 35-day worms, 32-day worms, 30-day worms, 28-day worms, 21-day, 15-day, 7-day, and 4-day schistosomule. RNA was isolated using the RNA-STAT-60 Kit (Tel-Test) following the manufacturer's instructions. To prepare total cDNA, 5 µg of total RNA was used as template for each 50-µl reaction. A total reaction volume of 31 µl containing RNA, RNasin (Promega), 1 µg of oligo(dT), 0.1 µg of random hexamers (Life Technologies, Inc.), and water were incubated for 10 min at 70 °C. After incubation, 1st strand buffer (Life Technologies, Inc.), 0.01 M dithiothreitol, 0.4 mM dNTPs, and 400 units of Superscriptase (Life Technologies, Inc.) were added to each reaction. After incubation at 37 °C for 1 h, 0.5 µl of reaction mix was used as template for PCR. SmRXR-specific oligonucleotides were synthesized for PCR: 5' AACAGATCTACCTAATTTAACATAC-OH (aa 434-441) as forward primer and 5' GCACGTAGTAAAGCTAATTCAG-OH (aa 581-588) as reverse primer. alpha -Tubulin-specific primers (16) were used in each reaction as a constitutively expressed gene control. To remain in the linear range of PCR, 28 cycles were performed. The PCR products were size-separated on a 1.5% agarose gel, visualized by ethidium bromide staining, and quantified by the Molecular Analyst program, PC version 1.5 (Bio-Rad). The amount of SmRXR PCR product was compared within each reaction to alpha -tubulin product and then this value was compared among the developmental stages.

Construction of Yeast One-hybrid Target Reporter Strains-- The Matchmaker One-hybrid System protocol () was followed with a few exceptions. The target-reporter construct pHisi-154, was made by inserting a 154-base pair DNA fragment, delineating nucleotides -220 to -60 of the p14 gene (Fig. 1), repeated 3 times upstream of the His3 promotor in the pHISi-1 vector. Target-reporter construct, pHisi-EL1, was made by inserting the DNA fragment, 5' TTGACATTTTTAACTATCACGCTCAACTATCATT-OH (Fig. 1) repeated six times upstream of the His3 promotor. After preparing competent YM4271 yeast cells as directed by , 10 µg of the target-reporter construct was used for transformation. Yeast reporter strains were analyzed by Southern blot to ensure that proper integration of the target-reporter had occurred.

Analysis of SmRXR Activity in Vivo, Yeast One-hybrid Assay-- The competent reporter yeast strains were transformed with either pACT-2 activation domain vector () containing the SmRXR gene downstream of the Gal4-AD (pAC-RXR), pACT-2 vector, pADH1 expression vector containing the SmRXR (pADH-RXR), or pADH1 vector. The pADH1 vector is a 2-µm expression vector with a multi-cloning site upstream of a ADH1 promotor. Control transformations without DNA were also performed. In a sterile 15-ml conical tube, 10 µg of plasmid DNA, 200 µg of sheared salmon sperm DNA, and 330 µl of component reporter strain yeast cells were added. After mixing the DNA and yeast, 2 ml of LiAc/polyethylene glycol solution (10 mM Tris, pH 7.5, 1 mM EDTA, pH 7.5, 0.1 M LiAc, and 40% polyethylene glycol) were added, and the suspension was vortexed. The transformation suspension was incubated while shaking at 200 rpm at 30 °C for 30 min. After incubation, 230 µl of Me2SO were added and mixed by inverting the tube gently. Cells were incubated for 15 min at 42 °C and then placed on ice for 2 min. Cells were centrifuged at 1000 × g for 10 min, and the supernatant was aspirated. The pellet was resuspended in 2.3 ml of TE buffer. From the control tubes that contained reporter strains lacking DNA, 10 µl of cells were diluted 1:100 in TE and 200 µl per plate were spread onto SD/-his media containing 0, 15, 30, 45, and 60 mM 3-amino-1,2,4-triazole (AT, a HIS3 competitor). From each tube containing reporter yeast strains transformed with plasmid DNA, 100 µl, were spread onto SD/-leu to test transformation efficiency. All plasmids used contained the selection marker leu2 gene. From each of these tubes, 200 µl per plate were spread onto SD/-his-leu containing AT at concentrations of 0, 15, 30, 45, and 60 mM. The plates were incubated at 30 °C and checked each day for growth. On the 7th day, selected colonies were restreaked on SD/-his-leu plates containing AT.

Yeast Two-hybrid Assay-- Yeast two-hybrid assay, originally developed by Fields and Song (17), was performed with the HybriZAP II Two-hybrid System (Strategene) according to the directions supplied from the manufacturer. SmRXR cDNA was ligated into the binding domain vector, pAS2-1 () forming pAS-RXR. Control DNA included pGal4, p53/pSV40, and pLaminC/pSV40 (Stratagene). Yeast cells transformed with pAS-RXR, p53/pSV40, and pLaminC/pSV40 were plated on SD/-trp plates. Yeast transformed with pGal4 were spread on SD/-leu plates. After 1 week incubation at 30 °C, colonies were assayed for beta -galactosidase activity using the protocol.

In Vitro Transcription-Translation of SmRXR-- SmRXR cDNA was inserted into the pCITE vector (Novagen) forming pCITE-RXR and transcribed and translated using the Single Tube Protein System (Novagen). The manufacturer's protocol for [35S]methionine incorporation was followed except an additional 1.25 mM cold methionine was added to each 50-µl reaction. Negative control reactions with circular pCITE DNA were also performed. Samples were examined by SDS-polyacrylamide gel electrophoresis, followed by autoradiography and then used immediately.

Analysis of SmRXR Activity in Vitro, EMSA-- A 250-bp sequence of the p14 upstream region, nucleotides -300 to -50 (Fig. 1), was radiolabeled by PCR amplification of the fragment using [32P]dCTP. Every 20-µl reaction contained ZnSO4 buffer (4 mM Tris, 80 mM NaCl, 0.5 mM ZnSO4, 5% glycerol, 0.5 mM dithiothreitol, and 1 mM EDTA), 5 µg of poly(dI·dC), 12% glycerol, and 5 fmol of radiolabeled p14 template (18). Protein-DNA binding reactions contained 1 µl of transcription-translation lysate. In cold template competition reactions, unlabeled p14 template (250-bp fragment) was added in 10 and 100 × molar excess of the radiolabeled p14 probe. In competition reactions with nonspecific DNA, a 250-bp fragment cut form pET32a DNA (Novagen), was added in 10, 100, and 250 × molar excess of the p14 probe. The following DNA sequences were added in 10, 100, and 250 × molar excess for competition reactions: 5' TTGACATTTTTAACTATCACGCTCAACTATCATT-OH (direct repeat), 5' TTTAATAATGATGCACTTAGTGAGGCACAACTCTTC-OH (imperfect palindrome), and 5' TTCTAACGGTAGAATCAAAATAGTGAGTAATTCGTG-OH (Fig. 1). Binding reactions were incubated at 23 °C for 30 min and then loaded onto a 16-cm 4% acrylamide gel (6.75 mM Tris, pH 8, 1 mM EDTA pH 8, 3.3 mM sodium acetate, 0.05% bisacrylamide). Electrophoresis was performed with a 6.75 mM Tris, pH 8, 1 mM EDTA and 3.3 mM sodium acetate running buffer at 4 °C.

    RESULTS

Identification of a Schistosome RXR Homologue cDNA-- A 170-base pair DNA fragment that showed homology to RXRs was amplified using degenerate oligonucleotides representing conserved regions of RXR genes as primers and adult schistosome cDNA as template in PCR (Fig. 2). The sequence of the 5' primer used for PCR encodes for an amino acid sequence found in the second zinc finger of all members of retinoid receptors, RARs and RXRs (19-22). The sequence of the 3' primer encodes for an amino acid sequence of the hinge region that is identical in all identified RXRs and is not found in other members of the steroid receptor superfamily. After screening 400,000 plaques of a female adult worm lambda  ZAP cDNA library with the RXR homologous DNA fragment, seven positive clones were obtained. Restriction digest and sequencing demonstrated that all seven clones were identical. The nucleotide sequence of SmRXR translates into a protein of 743 amino acids with an approximate mass of 74 kDa. SmRXR is the largest reported RXR to date. Sizes of RXRs range from 410 amino acids for mRXRbeta to 508 amino acids for dUSP (11, 23, 24). Comparison of the deduced amino acid sequence of SmRXR to other RXRs reveals that this protein exhibits significant homology to the DNA binding domain and the dimerization domain of other members of the RXR family (Fig. 2). For example, comparison of the amino acids of the DNA binding domain of SmRXR (aa 271-336) to those amino acids in the same domain of hRXRalpha (aa 135-200) and dUSP (aa 104-169) shows identities of 69 and 68%, respectively (11, 22, 24, 25). The first zinc finger within the DNA binding domain of SmRXR has only four amino acid changes from that of hRXRalpha (25). The second zinc finger exhibits lower homology. Within the dimerization and ligand binding domain are heptad repeats (Fig. 2) containing hydrophobic amino acids at positions 1, 5, and 8 (21). These heptad repeats form a dimerization motif (21). The amino acids of the dimerization motif of SmRXR (aa 531-680) share 48 and 35% identity to those of hRXRalpha (aa 325-463) and dUSP (aa 357-506), respectively (11, 21, 24, 25). Adjacent to the heptad repeats at the amino and carboxyl ends of the dimerization and ligand binding domain are two sub-domains, tau i and tau c, respectively, known to be important for ligand-dependent transregulation in other members of the steroid hormone receptor superfamily (21, 26-32). The tau i sub-domain, thought to function in hormone-relieved repression, has 20-45% conservation among steroid receptors of vertebrates and arthropods (21, 33, 34). For example, there is 38-40% conservation of the tau i domains of vertebrate RARs and RXRs (21, 23, 25). Steroid hormone receptors of vertebrates within each subfamily, such as RXR, have at least 98% identity in the tau i domains (21-23). Homology of the tau i domain of dUSP to that of vertebrate RXR is 50% (11, 21-25). The tau i domain of SmRXR (aa 457-512) shares 13% identity to the tau i domain of hRXRalpha (aa 277-324) and 19% identity to the tau i domain of dUSP (aa 282-338) (11, 21-25). The tau c sub-domain, a small amphipathic helical structure located at the carboxyl end of the dimerization and ligand binding domain, is conserved only among steroid hormone receptors that share the same ligand (22, 23, 25-32). For example, the tau c sub- domains of mRXRbeta , hRXRbeta , and hRXRalpha , which bind 9-cis- retinoic acid, are identical to one another except for a single amino acid change of the last carboxyl terminus amino acid (23, 25, 27, 35). The tau c sub-domains of RARs, which bind all-trans-retinoic acid, are also identical to one another but are dissimilar to the tau c sub-domains of the vertebrate RXRs (22, 23, 25-27, 36-41). The tau c domain of dUSP is not homologous to vertebrate RXR tau c domains and does not bind to 9-cis-retinoic acid (24). Nine-cis-retinoic acid is not likely to be the ligand of SmRXR due to the variant sequence of the tau c domain.

Immunological Identification of SmRXR in Different Worm Stages-- Using an affinity purified antibody produced to a truncated form of recombinant GST-SmRXR, native SmRXR was identified in adult worm pair, mature male, mature female, and 3 h shistosomule extracts (Fig. 3). Native SmRXR has an approximate molecular mass of 74 kDa as observed in the Western blot (panel B). For a control, adult worm pair extract was probed with preimmune rabbit serum (panel C). There are irrelevant bands that appear on the Western blot, but none the 74-kDa size. These bands are not present in panel B because the serum was affinity purified.


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 3.   Identification of SmRXR in different worm stages by Western blot analysis. Panel A, 12.5% acrylamide gel stained with Coomassie Blue. Lane 1, adult worm pair extract; lane 2, mature male worm extract; lane 3, mature female worm extract; lane 4, 3-h schistosomule extract. Panel B, Western blot probed with affinity purified rabbit anti-SmRXR. Lanes 1-4 contain the same amount of schistosome extract and in the same order as panel A. An arrow points to the 74-kDa band in the extracts that are specific for anti-SmRXR. Panel C is a Western blot of adult worm extract probed with preimmune rabbit serum.

Developmental Expression of the SmRXR Gene-- RT-PCR was performed on total RNA isolated from various developmental stages to evaluate developmental expression of the SmRXR gene. In order to control for the expression of multiple schistosome RXR homologues, primers to non-conserved regions of SmRXR were used in the RT-PCR reactions. alpha -Tubulin-specific primers that represent a constitutive gene were added to each reaction. A 465-bp SmRXR cDNA fragment and a 500-bp alpha -tubulin product were amplified (Fig. 4). By comparing the amount of SmRXR PCR product to that of alpha -tubulin within each reaction and then comparing this value among the different life stages, we demonstrate that SmRXR is constitutively expressed throughout development (Fig. 4).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 4.   Quantification of SmRXR mRNA in different developmental stages. RT-PCR products were loaded onto a 1.5% agarose gel. RNA templates for the RT-PCR were adult worm pairs (A), male worms from a bisex infection (M), female worms from a bisex infection (F), immature females from a single sex infection (Fi), males from a single sex infection (Ms), and schistosomes collected 35, 32, 30, 28, 2, 15, 7, and 4 days post-infection, respectively. The PCR products were visualized by ethidium bromide stain. The upper bands are PCR products amplified using alpha -tubulin primers (16). The lower bands are PCR products amplified using SmRXR specific primers.

SmRXR Binds to the p14 Gene Upstream cis-Elements and Activates Transcription-- To determine if SmRXR binds to cis-elements of the p14 upstream region and drives transcription of a female-specific gene, we employed the yeast one-hybrid system. The reporter yeast strains, YTR-154, YTR-EL1, and YTR-pHisi, were transformed with pAC-RXR and pAC-2. YTR-154 transformed with salmon sperm DNA alone only grew on SD/-his media. This is expected because the His3 promotor is leaky. Therefore, growth of YTR-154 transformed with pAC-RXR on SD/-his-leu media with even low concentrations of aminotriazole would be a result of SmRXR-AD fusion protein binding to cis-elements of p14 and driving transcription of the HIS3 gene. The transformed YTR-154 cells were spread on SD/-his-leu plates with increasing amounts of AT. After 7 days of incubation, two classes of colonies grew that ranged from 0.25 to 0.5 mm in size and from 1.5 to 2.5 mm in size (data not shown). Colonies of both sizes were picked and streaked on SD/-his-leu plates containing up to 60 mM aminotriazole. The smaller colonies did not grow. The larger colonies grew on SD/-his-leu containing 60 mM AT (Fig. 5A). YTR-154 cells transformed with pAC-2 grew as small colonies (0.25-0.5 mm) in the original spreads. These colonies were picked and streaked on SD/-his-leu containing a range of AT concentrations. At 15 mM AT these colonies failed to grow on SD/-his-leu (Fig. 5A). The negative control strain YTR-pHisi, transformed with either pAC-RXR or pAC-2, grew as small colonies in the original spread but failed to grow when restreaked on media containing AT (data not shown). Therefore, it is evident that SmRXR fused to the Gal4 activation domain binds to cis-elements of p14 and drives transcription of the HIS3 reporter gene in the one-hybrid system.


View larger version (90K):
[in this window]
[in a new window]
 
Fig. 5.   Demonstration of SmRXR activity expressed in yeast. Panel A, individual YTR-154 colonies transformed with pAC-RXR (1-5) and pAC-2 (6) were streaked on SD/-his-leu plates containing 60 mM AT. Panel B, individual YTR-EL1 colonies transformed with pAC-RXR (1-5) and pAC-2 (6) were restreaked on SD/-his-leu plates containing 60 mM AT. Panel C, restreaks of individual YTR-154 transformed with pADH1-RXR (1-5) and pADH1 (6) on SD/-his-leu containing 60 mM AT. Panel D, YTR-EL1 transformed with pADH-RXR (1-5) and pADH1 (6) on selective media with 60 mM AT. Above each plate is a cartoon showing the target element inserted upstream of the His3 reporter gene in the yeast strains. Whether or not SmRXR, expressed in the yeast strains, is fused to the Gal4 activation domain is also depicted in the schematics.

To define further the interaction between the p14 gene and SmRXR-AD, YTR-EL1 that contained the direct repeat of the upstream region of p14 (Fig. 1) was used. As with the YTR-154 strain, after transformation with pAC-RXR there were larger colonies at higher concentrations of AT. YTR-EL1 cells grew best on 45 mM AT but did grow at 60 mM AT, at a slower rate. On the restreak plates it only took 3 days for YTR-154 growth to appear on SD/-his-leu containing 60 mM AT, whereas it took 5-6 days for growth of YTR-EL1 to appear on plates containing 60 mM AT (Fig. 5B). Growth of YTR-EL1 appeared on day 4 on the plates with 45 mm AT. Fig. 5B shows growth of five individual colonies of YTR-EL1 on 60 mm AT. The negative control included in this experiment was YTR-EL1 transformed with pAC-2 alone. Again there were small background colonies on the original spread that did not grow on the restreak (Fig. 5B). Therefore SmRXR-AD binds to the sequence including the direct repeat and enhances the transcription of the HIS3 gene.

Because RXR forms heterodimers in many species (42-50), we attempted to employ the yeast two-hybrid system to obtain schistosome clones that express proteins that interact with SmRXR. As a control, we transformed Y190 yeast cells with pAS-RXR, the bait plasmid containing the GAL4 DNA binding domain. SmRXR alone activated beta -galactosidase expression (data not shown). This result indicated that SmRXR by itself may activate gene transcription, perhaps as a homodimer, or by interacting with yeast proteins. In order to determine if SmRXR by itself, or perhaps with the help of a yeast protein, could drive transcription when recognizing cis-elements of p14, SmRXR was cloned into an expression vector that lacked the Gal4 activation domain and DNA binding domain (pADH-RXR). When YTR-154 was transformed with pADH-RXR, the cells as in the case of transformation with pAC-RXR (above) grew on SD/-his-leu media. There were very small colonies, 0.25-0.05 mm in size, and larger colonies, 1.5-2.5 mm in size. Again the smaller colonies did not grow after being restreaked on SD/-his-leu plates containing AT, but the larger colonies grew on SD/-his-leu containing 60 mM AT (Fig. 5C). Growth of these colonies appeared at day 3 on the restreak plates containing 60 mM AT. As in the above experiment, YTR-154 transformed with salmon sperm alone grew only on SD/-his media without AT. Therefore, SmRXR is binding to cis-elements of the p14 upstream region and driving transcription of the HIS3 gene without the Gal4 activation domain. Controls of this experiment included transforming YTR-154 with pADH1. Again small colonies grew on all the plates of the orginal spread but did not grow on SD/-his-leu media containing aminotriazole after the restreak (Fig. 5C). Similar to the above experiment YTR-pHisi, transformed with both pADH-RXR and pADH1, grew on all plates of the original streak but not after the restreak (data not shown).

YTR-EL1 cells were also transformed with pADH-RXR. Yeast colonies grew on SD/-his-leu containing 60 mM AT (Fig. 5D). Growth of these colonies on media containing 60 mM AT was slower than YTR-154 transformed with pADH-RXR and YTR-EL1 transformed with pAC-RXR. Growth of YTR-EL1 transformed with pADH-RXR on the restreak plates containing 60 mM AT appeared on days 6 and 7 depending on the clone. Small colonies grew on plates that contained YTR-EL1 transformed with pADH1, but these colonies did not grow when restreaked on SD/-his-leu containing AT. Indeed, SmRXR binds to the sequence containing the direct repeat (Fig. 1) and drives transcription of HIS3 (Fig. 5D).

EMSA Analysis of SmRXR-DNA Interactions-- EMSA were performed to study the in vitro interaction between p14 DNA and SmRXR. A 250-bp sequence, nucleotides -300 to -50, of the p14 upstream region (Fig. 1) was used as a probe in gel shift assays to determine whether or not SmRXR, synthesized by in vitro coupled transcription/translation, binds to RXR recognition sites. Shown in lane 1 of Fig. 6 is the probe without lysate from the transcription-translation mix. In lane 2, the binding reaction contains lysate from a transcription-translation reaction with pCITE vector used as template. There are a few irrelevant shifts of the probe caused by contents of the lysate binding to the p14 probe. In lane 3 it is apparent that SmRXR causes unique shifts of the radiolabeled p14 fragment. These shifts are denoted by the two arrows (Fig. 6). When cold p14 DNA is added in 100 × molar amount (lanes 4 and 5), the upper shift is competed, whereas the lower shift identified by the arrow is competed to a much lesser extent. Nonspecific DNA (lanes 6-8) does not interfere with the changes in electrophoretic mobility. Therefore, the shifts observed in lane 3 are specific for SmRXR-p14 interaction. The direct repeat competes the shifts to a great extent (lanes 9-11). At 250 ×, the competitor completely competes the two shifts denoted by both arrows. The DNA fragment that includes the sequence GTAGAATCA, competes the upper shift slightly at 250 × molar amounts (lane 14). The sequence that includes the imperfect palindrome (lanes 15-17) competes the upper shift at 100 × and at 250 × competes both shifts. In vitro studies demonstrate that the direct repeat sequence of the p14 gene is a preferential binding site for SmRXR.


View larger version (77K):
[in this window]
[in a new window]
 
Fig. 6.   Demonstration of SmRXR DNA binding activity by EMSA. Lane 1, DNA alone. Lane 2, lysate from the control transcription-translation reaction. Lane 3, lysate containing in vitro translated SmRXR. Lanes 4 and 5, binding reactions contained cold p14 competitor in 10 and 100 × amounts, respectively. Lanes 6-8, binding reactions contained a 250-bp fragment of a irrelevant DNA competitor in 10, 100, and 250 × amounts, respectively. Lanes 9-17, binding reactions contained 10, 100, and 250 × amounts of three different DNA sequences, the direct repeat, a sequence containing GTAGAATCA, and the imperfect palindrome sequence, respectively (Fig. 1). Arrows denote unique shifts caused by SmRXR-p14 interaction.


    DISCUSSION

Schistosomes are the only trematodes with separate sexes. This fact has driven the evolution of an interesting biological interplay between the sexes, such that the male through an unknown stimulus is able to regulate female-specific gene expression (2). A number of female-specific genes have been isolated, but as of yet no factors directly involved in the regulation of female-specific genes have been identified. In this paper we report the identification of SmRXR cDNA and provide evidence for its involvement in female-specific gene expression.

Members of the RXR subfamily in other species are important in the regulation of sex-, tissue-, and temporal- specific genes. For example, USP of Drosophila is employed in the regulation of chorion genes, embryogenesis, larval development, and pupation (11, 12, 45). This pleiotrophy of function is representative of RXR subfamily members. RXRs are known to form heterodimers with various partners that are essential for the regulation of a number of genes involved in homeostasis and development (45-50). Examples of RXR partners include the ecdysone receptor of Drosophila, vitamin D receptor, thyroid hormone receptor, and retinoic acid receptors (RAR) (42-50). When RXR forms heterodimers, such as RXR/RAR and USP/ecdysone receptor, the conformation of its binding partner changes allowing a greater affinity not only for the DNA response element but also for the ligand (43-51). RT-PCR results demonstrated that SmRXR mRNA is constitutively expressed throughout schistosome development, not only in mature females as are the female-specific genes (2, 3, 7, 9, 10). Furthermore, Western blot analysis showed that the 74-kDa SmRXR protein is present in both sexes, mature and immature. This demonstrates that SmRXR is not female-specific and suggests that, like other members of the RXR subfamily, SmRXR is important in the regulation of a number of genes. Future studies will entail identifying SmRXR-binding partners involved in the regulation of female-specific genes and defining the putative role(s) SmRXR plays in the regulation of other genes.

To date, a genetic system to study the functions of schistosome genes in vivo does not exist. Therefore, evidence for the involvement of SmRXR in female-specific gene regulation was obtained by the yeast one-hybrid system and EMSA analysis. In these studies, we showed that SmRXR binds to cis-elements of the p14 gene and drives transcription of a reporter gene in yeast. Members of the steroid receptor superfamily commonly bind to cis-elements that consist of two half-sites spaced by 3, 4, or 5 nucleotides (13, 14). EMSA analysis demonstrates that the preferential binding site for SmRXR, in vitro, is a sequence containing the half-site AACTATCA spaced by five nucleotides (Fig. 1). In the upstream region of s15, a Drosophila chorion gene, the sequence TCACGT is an essential part of an imperfect palindrome known to be a USP response element (12). Interestingly, a similar sequence, TCACGCT, occupies the 3' end of the first half-site and part of the spacer region of the direct repeat in the p14 gene upstream region (Fig. 1). To define the region of the p14 gene involved in SmRXR binding interaction and trans-activation, the direct repeat sequence was used as a target element in the one-hybrid assay. SmRXR most likely acts as a homodimer to drive transcription of this chimeric reporter gene. It is unlikely that SmRXR interacts with a yeast protein. RXRs have been shown to form heterodimers with only members of the steroid receptor family, and to date, steroid receptors have not been identified in yeast (42-50).

An evolutionary study was performed to better understand the function of SmRXR. Knowing the rate at which SmRXR has evolved as compared with other RXRs and RARs may answer questions about how it functions in regulating gene expression. Steroid receptors have recently been identified in early metozoans, such as cnidarians and schistosomes (52). Interestingly, in a nuclear receptor evolutionary study, the DNA binding domain of a schistosome RXR homologue, which is not identical to the SmRXR cDNA identified in our lab, was described (52). The divergence of subfamilies of the steroid superfamily was previously determined to have occurred before the divergence of the arthropods and vertebrates (22, 53) (Fig. 7). From the Escriva et al. (52) study and the phylogenetic tree designed using full-length cDNA sequences of RXRs and RARs shown in this report (Fig. 7), the above statement can be extended to note that the divergence of subfamilies occurred before the divergence of cniderians and platyhelminthes (52, 53). Because SmRXR is deeply rooted in evolution (Fig. 7), comparison of this gene with other steroid receptors may lead to the identification of the original ancestor of the steroid receptor family.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 7.   Evolutionary tree showing the phylogenetic relationship between SmRXR and RXRs and RARs of vertebrates and arthropods. The node numbers are in bold. The assigned branch numbers representing evolutionary distance are in parentheses. Starting from node one, the common name and GenBankTM accession numbers of the protein sequences used in the PAUPsearch analysis are as follows: mRARalpha , mouse, P11416; mRARbeta , mouse, P22605; hRARalpha , human, P10276; hRXRbeta , human, P28702; mRXRbeta , mouse, P28704; hRXRalpha , human, P19793; mRXRalpha , mouse, P28700; xenRXRalpha , Xenopus, P51128; hRXRgamma , human, P48443; mRXRgamma , mouse, P28705; chRXRalpha , chicken, P28701; xenRXRgamma , Xenopus, P51129; cf1bRXR, silkworm, P49700; manseUSP, tobacco hornworm, P54779; dUSP, Drosophila, P20153; mHNF4, mouse, P49698; smRXR, schistosome, AF094759. From top to bottom, the vertebrate RARs are in one group, branching from node 32; the vertebrate RXRs have node 26 in common. Mouse hepatocyte nuclear receptor (mHNF), an ancient vertebrate steroid receptor (53), is more deeply rooted than the arthropod RXRs that branch from node 28. To our knowledge, SmRXR is the most ancient RXR of which the full-length cDNA sequence has been identified.

The trans-activating function of steroid receptors is often dependent on dimerization and ligand binding (22, 42-50). Ligand binding is thought to change the conformation of the steroid receptor into an active state (51). The ability of members of the RXR subfamily to bind specific ligands appears to have evolved after the vertebrate and arthopod lineages diverged, as of yet ligands have not been found for arthropod RXRs (22, 45, 52, 53). The tau c sub-domain, important for ligand binding specificity, of arthropod RXR homologues and SmRXR shows minimal homology to one another and to vertebrate RXRs (22, 23, 25-32). This suggests that if these more ancient receptors have evolved to bind ligands, they do not bind the same ligand. However, arthropod RXRs, like their vertebrate homologues, do form dimers with other proteins. For example, dUSP dimerizes with the ecdysone receptor (42-44). Upon sequence analysis of SmRXR, it is evident that the heptad repeats that form dimerization interfaces on one side of an alpha -helix exist in this protein (21). This suggests that, like other steroid receptors, SmRXR forms dimers that function in trans-activation (42-50). The fact that SmRXR and dUSP putatively do not bind ligands, yet have the ability to form dimers, suggests that tau c and the dimerization interface have evolved at different rates (22, 23, 25-32, 45, 51, 52). Comparing the function of early metozoan, arthropod, and vertebrate RXRs will lead to a greater understanding of the importance of these two sub-domains in RXR facilitated trans-activation.

This report provides the first evidence that RXRs play a role in gene regulation in primitive eukaryotic organisms such as schistosomes. Not only does this study add to an increasing amount of information on the evolution of steroid receptors but also has initiated the study of steroid receptors involved in a very intriguing interplay between the separate sexes of schistosomes and the regulation of female-specific genes. The study of steroid receptors, such as SmRXR, involved in female-specific gene regulation may lead to pharmacological compounds that prevent female maturation and egg production, thereby controlling schistosomiasis.

    ACKNOWLEDGEMENTS

We thank Dr. Dan Kosman, State University of New York at Buffalo, for providing the pADH1 vector; Dr. Claude Mania, New England Biolabs, for sharing unpublished sequences of RXR family members; Dr. Stephen Elledge, Baylor College of Medicine, for the host yeast strain Y190; and Dr. Michael Garrick, SUNY at Buffalo, for providing advice on evolutionary studies.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant AI27219.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF094759.

To whom correspondence should be addressed: Dept. of Microbiology, 138 Farber Hall, State University of New York, Buffalo, NY 14214. Tel.: 716-829-2459; Fax: 716-829-2169; E-mail: loverde{at}buffalo.edu.

    ABBREVIATIONS

The abbreviations used are: RXR, retinoid X receptor; Sm, Schistosoma mansoni; EMSA, electrophoretic mobility shift assays; aa, amino acids; USP, ultraspiracle protein; GST, glutathione S-transferase; Gal4-AD, Gal4 activation domain; SD, synthetic dropout; AT, 3-amino-1,2,4-triazole; mRXRbeta , mouse RXRbeta ; dUSP, Drosophila USP; hRXRalpha , human RXRalpha ; RAR, retinoic acid receptor; RT-PCR, reverse transcriptase-polymerase chain reaction; bp, base pair.

    REFERENCES
Top
Abstract
Introduction
References
  1. Engers, H. D., Bergquist, R., and Modabber, F. (1996) Dev. Biol. Stand. 87, 73-84[Medline] [Order article via Infotrieve]
  2. LoVerde, P. T., and Chen, L. (1991) Parasitol. Today 7, 303-308[Medline] [Order article via Infotrieve]
  3. Chen, L., Rekosh, D., and LoVerde, P. (1992) Mol. Biochem. Parasitol. 52, 39-52[CrossRef][Medline] [Order article via Infotrieve]
  4. Menrath, M., and Kunz, W. (1995) Parasitology 111, 477-483[Medline] [Order article via Infotrieve]
  5. Schubler, P., Grevelding, C. G., and Kunz, W. (1997) Parasitology 115, 629-634[CrossRef][Medline] [Order article via Infotrieve]
  6. Grevelding, C. G., Sommer, G., and Kunz, W. (1997) Parasitology 115, 635-640[CrossRef][Medline] [Order article via Infotrieve]
  7. Bobek, L., Rekosh, D., Van Keulen, H., and LoVerde, P. T. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 5544-5548[Abstract]
  8. Koster, B., Dargatz, H., Schroder, J., Hirzmann, J., Haarmann, C., Symmons, P., and Kunz, W. (1988) Mol. Biochem. Parasitol. 31, 183-198[Medline] [Order article via Infotrieve]
  9. Bobek, L., LoVerde, P., Van Keulen, H., and Rekosh, D. (1987) Mol. Cell. Biol. 42, 133-143
  10. Bobek, L., Rekosh, D., and LoVerde, P. T. (1988) Mol. Cell. Biol. 8, 3008-3016[Medline] [Order article via Infotrieve]
  11. Shea, M., King, D., Conboy, M., Mariani, B., and Kafatos, F. (1990) Genes Dev. 4, 1128-1140[Abstract]
  12. Christianson, A. M. K., King, D., Hatzivassilou, E., Casas, J., Hallenbeck, P., Nikodem, V., Mitsialis, S. A., and Kafatos, F. C. (1992) Proc. Natl. Acad Sci. U. S. A. 89, 11503-11507[Abstract]
  13. Umesono, K., Murakami, K., Thompson, C., and Evans, R. (1991) Cell 65, 1255-1266[Medline] [Order article via Infotrieve]
  14. Naar, A., Boutin, J., Lipkin, S., Yu, V., Holloway, J., Glass, C., and Rosenfeld, M. (1991) Cell 65, 1267-1279[Medline] [Order article via Infotrieve]
  15. Beal, J. A., and Mitchell, G. F. (1986) J. Immunol. Methods 86, 217-223[CrossRef][Medline] [Order article via Infotrieve]
  16. Mei, H., and LoVerde, P. T. (1997) Exp. Parasitol. 86, 69-78[CrossRef][Medline] [Order article via Infotrieve]
  17. Fields, S., and Song, O. (1982) Nature 340, 245-246
  18. Gogos, J. A., Hsu, T., Bolton, J., and Kafatos, F. C. (1992) Science 257, 1951-1955[Medline] [Order article via Infotrieve]
  19. Kumar, M., de Verneuil, H., and Chambon, P. (1989) Nature 338, 271-274[CrossRef][Medline] [Order article via Infotrieve]
  20. Umesono, K., and Evans, R. M. (1989) Cell 57, 1139-1146[Medline] [Order article via Infotrieve]
  21. Forman, B. M., and Samuels, H. (1990) Mol. Endocrinol. 4, 1293-1301[Abstract]
  22. Mangelsdorf, D., Kliewer, S., Kakizuka, A., Umesono, K., and Evans, R. (1993) Recent Prog. Horm. Res. 48, 99-121[Medline] [Order article via Infotrieve]
  23. Mangelsdorf, D., Borgmeyer, U., Heyman, R., Zhou, J. Y., Ong, E. S., Oro, A. E., Kakizuka, A., and Evans, R. (1992) Genes Dev. 6, 329-344[Abstract]
  24. Henrich, V. C., Sliter, T. J., Lubahn, D. B., MacIntyre, A., and Gilbert, L. I. (1990) Nucleic Acids Res. 18, 4143-4148[Abstract]
  25. Mangelsdorf, D. J., Ong, E. S., Dyck, J. A., and Evans, R. M. (1990) Nature 345, 224-229[CrossRef][Medline] [Order article via Infotrieve]
  26. Baniahmad, A., Leng, X., Burris, T. P., Tsai, M. J., and O'Malley, B. W. (1995) Mol. Cell. Biol. 15, 76-86[Abstract]
  27. Leng, X., Blanco, J., Tsai, S. Y., Ozato, K., O'Malley, B. W., and Tsai, M. J. (1995) Mol. Cell. Biol. 15, 255-263[Abstract]
  28. Barettino, D., del Mar Vivanco Ruiz, M., and Stunnenberg, H. G. (1994) EMBO J. 13, 3039-3049[Abstract]
  29. Durand, B., Saunders, M., Gaudon, C., Roy, B., Losson, R., and Chambon, P. (1994) EMBO J. 13, 5370-5382[Abstract]
  30. Flynn, T. R., Hollenberg, A. N., Cohen, O., Menke, J. B., Usala, S. J., Tollin, S., Hegarty, M. K., and Wondisford, F. E. (1994) J. Biol. Chem. 269, 32713-32716[Abstract/Free Full Text]
  31. Zhang, X. K., Salbert, G., Lee, M. O., and Pfahl, M. (1994) Mol. Cell. Biol. 14, 4311-4323[Abstract]
  32. Schulman, I. G., Juguilon, H., and Evans, R. (1996) Mol. Cell. Biol. 16, 3807-3813[Abstract]
  33. McDonnell, D. P., Pike, J. W., and O'Malley, B. W. (1988) J. Steroid Biochem. 30, 41-46[CrossRef][Medline] [Order article via Infotrieve]
  34. Wang, L. H., Tsai, S. Y., Cook, R. G., Beattle, W. G., Tsai, M. J., and O'Malley, B. W. (1989) Nature 340, 163-166[CrossRef][Medline] [Order article via Infotrieve]
  35. Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R., Eichele, G., Evans, R. M., and Thaller, C. (1992) Cell 68, 397-406[Medline] [Order article via Infotrieve]
  36. Giguere, V., Ong, E. S., Segui, P., and Evans, R. M. (1987) Nature 330, 624-629[CrossRef][Medline] [Order article via Infotrieve]
  37. Petkovich, M., Brand, N. J., Krust, A., and Chambon, P. (1987) Nature 330, 444-450[CrossRef][Medline] [Order article via Infotrieve]
  38. Brand, N., Petkovich, M., Krust, A., Chambon, P., de The, H., Marchio, A., Tiollais, P., and Dejean, A. (1988) Nature 332, 850-853[CrossRef][Medline] [Order article via Infotrieve]
  39. Zelent, A., Krust, A., Petkovich, M., Kastner, P., and Chambon, P. (1989) Nature 339, 714-717[CrossRef][Medline] [Order article via Infotrieve]
  40. Krust, A., Kastner, P., Petkovich, M., Zelent, A., and Chambon, P. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 5310-5314[Abstract]
  41. Ishikawa, T., Umesono, K., Mangelsdorf, D. J., Aburtani, H., Stanger, B. Z., Shibasaki, Y., Imawari, M., Evans, R. M., and Takaku, F. (1990) Mol. Endocrinol. 4, 837-844[Abstract]
  42. Yao, T., Segraves, W., Oro, A., McKeown, M., and Evans, R. (1992) Cell 71, 63-72[Medline] [Order article via Infotrieve]
  43. Thomas, H., Stunnenberg, H., and Stewart, A. F. (1993) Nature 362, 471-475[CrossRef][Medline] [Order article via Infotrieve]
  44. Yao, T., Forman, B., Jiang, Z., Cherbas, L., Chen, J., McKeown, M., Cherbas, P., and Evans, R. (1993) Nature 366, 476-479[CrossRef][Medline] [Order article via Infotrieve]
  45. Oro, A. E., McKeown, M., and Evans, R. (1992) Development 115, 449-462[Abstract]
  46. Yu, V., Delsert, C., Andersen, B., Holloway, J., Devary, O., Naar, A., Kim, S., Boutin, J., Glass, C., and Rosenfeld, M. (1991) Cell 67, 1251-1266[Medline] [Order article via Infotrieve]
  47. Zhang, X., Hoffmann, B., Tran, P., Graupner, G., and Pfahl, M. (1992) Nature 355, 441-446[CrossRef][Medline] [Order article via Infotrieve]
  48. Leid, M., kastner, P., Lyons, R., Nakshatri, H., Saunders, M., Zacharewski, T., Chen, J., Staub, A., Garnier, J., Mader, S., and Chambon, P. (1992) Cell 68, 377-395[Medline] [Order article via Infotrieve]
  49. Leng, X., Blanco, J., Tsai, S., Ozato, K., O'Malley, B., and Tsai, M. (1994) J. Biol. Chem. 269, 31436-31442[Abstract/Free Full Text]
  50. Valcarcel, R., Holz, H., Jimenez, C., Barettino, D., and Stunnenberg, H. (1994) Genes Dev. 8, 3068-3079[Abstract]
  51. Schulman, I. G., Juguilon, H., and Evans, R. M. (1996) Mol. Cell. Biol. 16, 3807-3813[Abstract]
  52. Escriva, H., Safi, R., Hanni, C., Langlois, M., Saumitou-Laprade, P., Stehelin, D., Capron, A., Pierce, R., and Laudet, V. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 6803-6808[Abstract/Free Full Text]
  53. Laudet, V., Hanni, C., Coll, J., Catzeflis, F., and Stehelin, D. (1992) EMBO J. 11, 1003-1013[Abstract]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.